ILDONG PHARMACEUTICAL CO.
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Yunovia Announces IND Approval by the MFDS to Initiate Phase 1 MAD Study for the Small Molecule GLP-1 Agonist 2024-08-28 10:43
Ildong Pharmaceutical starts Phase 1 study of new diabetes therapy in Germany 2021-07-01 21:00
1